Charlotte's Web Holdings, Inc.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- William Morachnick
- Full Time Employees
- 112
- Sector
- Process industries
- Industry
- Agricultural commodities/Milling
- Address
- 700 Tech Court Louisville CO United States 80027
- IPO Date
- Aug 29, 2018
- Website
- charlottesweb.com
- Similar Companies
- Business
- Charlotte's Web Holdings, Inc. (TSX: CWEB) leads the market in the production and distribution of innovative hemp-derived cannabidiol (CBD) wellness products, including full-spectrum and broad-spectrum hemp extracts containing CBD, CBN, CBC, CBG, THC, terpenes, flavonoids, and other beneficial botanical compounds; its core offerings encompass CBD oil tinctures, gummies for sleep, calming, exercise recovery, immunity, focus, and attention, CBN gummies, hemp-derived THC microdose gummies under the Brightside brand with TiME INFUSION technology for rapid onset, functional mushroom gummies, CBD capsules, topical creams and lotions, and pet products for dogs, marketed under the Charlotte’s Web, CBD CLINIC, CBD MEDIC, and Brightside brands. The Certified B Corporation, founded in 2013 by the Stanley Brothers and headquartered at 700 Tech Court in Louisville, Colorado, operates a vertically integrated model with proprietary U.S. farm-grown hemp genetics, in-house FDA-registered manufacturing, and rigorous third-party testing from soil to shelf; it distributes through direct-to-consumer e-commerce, omnichannel platforms including TikTok Shop, Amazon, Walmart.com, and Faire, retailers, healthcare practitioners, and select distributors across the United States, emphasizing quality, consistency, and science-backed innovation in the botanical wellness sector. Recent developments include the full internalization of Brightside gummy production in 2025 for multi-million-unit capacity and cost savings, expansion of the sleep portfolio to five products across brands with strong traction for CBN Stay Sleep and Knockout THC gummies, entry into nootropics with CBG Focus & Attention Gummies, ongoing growth in functional mushrooms launched late 2024, strategic B2B retail restructuring in Q3 2025 reducing direct sales force amid regulatory shifts for improved profitability and focus on high-margin medical channels, formation of a Scientific Advisory Board led by Chief Scientific Officer Dr. Marcel Bonn-Miller to advance clinical validation and continuing medical education, FDA clearance for Phase 2 trials of DeFloria IND—a collaboration with Ajna BioSciences and British American Tobacco funding—for autism irritability treatment where Charlotte's Web holds exclusive manufacturing rights, and appointment of M. Borgia Walker from BAT to the board effective November 1, 2025, alongside cost optimizations targeting $9 million in annualized savings for 2026 positive cash flow trajectory.
Company News
Charlotte's Web Applauds Congressional Action to Advance Continuing Resolution
Charlotte's Web and Edibles.com Team up to Protect Consumer Access and Shape Hemp's Future
Charlotte's Web Launches Route CBD to Support Californians Who Depend on Full-Spectrum Hemp CBD
Charlotte's Web Reports Second Quarter 2026 Financial Results
Charlotte's Web Welcomes Senate Passage of Hemp Extension Marking Important Progress Toward a Long-Term Federal Hemp Framework
Charlotte's Web Provides Update on Diverging Hemp Policies: Federal Momentum Builds as California Restricts Therapeutic Hemp Product Access
Charlotte's Web Announces Board Transition as Co-Founder Jared Stanley Deepens Focus on DeFloria
Charlotte's Web Appoints Jeff Raborn to Board of Directors
Charlotte's Web Announces Closing of Transaction with British American Tobacco, Including US$10 Million Investment
Charlotte's Web Reports Shareholder Meeting Voting Results
Charlotte's Web First Quarter 2026 Financial Results
CURED Nutrition Joins One Hemp, Strengthening Industry Alignment Ahead of Key Federal Legislative Deadline
Charlotte's Web Holdings, Inc. (CWEB:CA) Q4 2025 Earnings Call Transcript
Charlotte's Web Reports 2025 Fourth Quarter and Full Year Financial Results
Charlotte's Web Announces Transaction with BAT: Debenture Conversion and US$10M Equity Investment to Strengthen Balance Sheet
Charlotte's Web 2025 Fourth Quarter and Year-End Earnings Call and Webcast Notice
Charlotte's Web Welcomes New CMS Guidance, Advancing Access to Eligible Full‑Spectrum Hemp Products
Charlotte’s Web (OTCMKTS:CWBHF) Stock Price Up 3.4% – Time to Buy?
Charlotte's Web Commends Representative Griffith for Leadership Introducing Hemp Enforcement, Modernization, and Protection (HEMP) Act
Presidential Executive Order Validates DeFloria's Strategy in Pharmaceutical Cannabinoid Drug Development